Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II hemodynamic dose-finding study of istaroxime in hospitalized worsening chronic heart failure
2005-004972-20Phase 2Completed
- Sponsor
- Leadiant Biosciences
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of istaroxime in chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD), sponsored by Leadiant Biosciences. Primary endpoint: Pulmonary capillary wedge pressure. Started Jan 2007; status: completed.
02
Drugs
istaroxime
03
Conditions
chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2005-004972-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004972-20.